Leveraging External Partnerships to Maximize the Value of a Top-5 Pharma’s Portfolio

In the face of constrained R&D budgets, a top-5 pharmaceutical company needed support to develop a transformative, corporate-wide strategy to assess and secure external funding.

Following an extensive global assessment and documentation of the external funding landscape, Shift Health advanced a bold strategic and operational framework to position the company to be proactive, flexible and consistent in its approach to external funding and maximize how opportunities are developed, evaluated, negotiated and secured.

Shift Health’s contribution has shifted the culture of partnership across the organization—amplifying the company’s presence and probability of success in the dynamic external funding arena.